References
Bortin MM, Truitt RL, Rimm AA, Bach FH (1979) Graft-versus-leukeamia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity. Nature 281:490
Bowen JG, Baldwin RW (1979) Tumour antigens and alloantigens. II. Lack of association of rat hepatoma-D23-specific antigen with β2-microglobulin. Int J Cancer 23:833
Burton RC, Chism SE, Warner NL (1978) In vitro induction and expression of T-cell immunity to tumor-associated antigens. Curr Top Immunobiol 8:69
Callahan GN, Allison JP, Pellegrino MA, Reisfeld RA (1979) Physical association of histocompatibility antigens and tumor-associated antigens on the surface of murine lymphoma cells. J Immunol 122:70
Carey TE, Ko L, Takahashi T, Travassos LR, Old LJ (1979) AU cell surface antigen of human malignant melanoma. Solubilization and partial characterization. Proc Natl Acad Sci USA 76:2898
Chauvenet PH, Smith RT (1978) Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific ttransplantation antigen strength. Int J Cancer 22:79
Collavo D, Parenti A, Biasi G, Chieco-Bianchi L, Colombatti A (1978) Secondary in vitro generation of cytolytic T-lymphocytes (CTL)s in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barriers. J Natl Cancer Inst 61:885
Curry RA, Quaranta V, Pellegrino MA, Ferrone S (1979) Serologically detectable human melanoma-associated antigens are not genetically linked to HLA-A and B antigens. J Immunol 122:2630
Faraldo MJ, Dux A, Mühlbock O, Hart G (1979) Histocompatibility genes (the H-2 complex) and susceptibility to spontaneous lung tumors in mice. Immunogenetics 9:383
Gomard E, Duprez V, Henin Y, Levy JP (1976) H-2 region product determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes. Nature 250:707
Haywood GR, McKhann CF (1971) Antigenic specificities on murine sarcoma cells. Reciprocal relationship between normal transplantation antigens (H-2) and tumor-specific immunogenicity. J Exp Med 133:1171
Holden HT, Landolfo S, Herberman RB (1977) Cell-dependent reactivity against tumor-associated antigens on allogeneic target cells. Transplant Proc 9:1149
Invernizzi G, Parmiani G (1975) Tumour-associated transplantation antigens of chemically induced sarcomata cross-reacting with allogeneic histocompatibility antigens. Nature 254:713
Klein G, Klein E (1975) Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens modified forms of H-2 or linked determinants? Int J Cancer 15:879
Martin WJ, Gipson TG, Conliffe M, Friedman RJ, Dove L, Rice JM (1977) Common tumor-associated transplantation alloantigen detected on a proportion of lung tumors induced transplacentally in several strains of mice. Transplantation 24:294
Mathé G, Olsson L (1979) Systemic active immunotherapy is shifting from the Middle Ages to Renaissance period. II. Experimental models for cancer systemic immunotherapy and immunoprophylaxis. Cancer Immunol Immunother 6:197
Meruelo D, Deak B, McDevitt HO (1977) Genetic control of cell-mediated responsiveness to an AKR tumor-associated antigen. Mapping of the locus involved to the I region of the H-2 complex. J Exp Med 146:1367
Oth D, Berebbi M, Meyer G (1975) Tumor-associated antigens in isoantigenic variants of a 3-methylcholanthrene-induced sarcoma. J Natl Cancer Inst 55:903
Parmiani G, Ballinari D (1979) Genetic control of in vivo immunity to tumor-specific transplantation antigens of chemically induced murine fibrosarcomas. Int J Cancer 23:697
Parmiani G, Meschini A, Invernizzi G, Carbone G (1978) Tumor-associated transplantation antigens distinct from H-2k-like antigens on a BALB/c (H-2d) fibrosarcoma. J Natl Cancer Inst 61:1229
Parmiani G, Carbone, G, Invernizzi G, Pierotti MA, Sensi M, Rogers MJ, Appella E (1979) Alien histocompatibility antigens on tumor cells. Immunogenetics 9:1
Parmiani G, Fossati G, Della Porta G (1980) Tumor antigens and histocompatibility antigens: an undefined relationship. Ric Clin Sper (to be published)
Rogers MJ, Law LW, Pierotti MA, Parmiani G (1980) Separation of the tumor-associated transplantation antigen (TATA) from the alien H-2k antigens expressed on a methylcholanthrene induced tumor. Int J Cancer 25:105
Russell JH, Ginns LC, Terres G, Eisen HN (1979) Tumor antigens as inappropriately expressed normal alloantigens. J Immunol 122:912
Snell GD, Dausset J, Nathenson S (1976) Histocompatibility. Academic, New York
Thomson DMP, Rauch JE, Weatherhead JC, Frielander P, O'Connor R, Grosser N, Shuster J, Gold P (1978) Isolation of human tumour-specific antigens associated with β2-microglobulin. Br J Cancer 37:753
Ting CC, Herberman RB (1971) Inverse relationship of polyoma tumour specific cell surface antigen to H-2 histocompatibility antigens. Nature New Biol 232:118
Ting CC, Law LW (1977) Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to leukemia-associated antigens. J Immunol 118:4
Trinchieri G, Aden DP, Knowles BB (1976) Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens. Nature 261:312
Williams RM, Dorf ME, Benacerraf B (1975) H-2 linked genetic control of resistance to histocompatibility tumors. Cancer Res 35:1586
Zarling JM, Robins HI, Raich PC, Bach FH, Bach ML (1978) Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells. Nature 274:269
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Parmiani, G. Histocompatibility antigens and tumour antigens. Cancer Immunol Immunother 8, 215–217 (1980). https://doi.org/10.1007/BF00206038
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00206038